Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Cell-based Quadrivalent Influenza Vaccine (Surface Antigen, Inactivated) Seqirus suspension for injection in pre-filled syringe {equilateral_black_triangle}

Active Ingredient:
influenza vaccine (surface antigen, inactivated)
Company:  
Seqirus UK Limited See contact details
ATC code: 
J07BB02
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 20 Jun 2024

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Seqirus UK Limited
Company image
Address
The Point, 29 Market Street, Maidenhead, SL6 8AA, UK
Medical Information Direct Line
+44 (0) 1748 828816
Medical Information e-mail
[email protected]
WWW
http://www.seqirus.com
Customer Care direct line
08457 451 500
Telephone
+44 (0)1628 641 500
Product Quality Complaints
[email protected]